360 related articles for article (PubMed ID: 32320695)
1. Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.
Claxton JS; Chamberlain AM; Lutsey PL; Chen LY; MacLehose RF; Bengtson LGS; Alonso A
Am J Med; 2020 Oct; 133(10):e554-e567. PubMed ID: 32320695
[TBL] [Abstract][Full Text] [Related]
2. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
Chamberlain AM; Alonso A; Gersh BJ; Manemann SM; Killian JM; Weston SA; Byrne M; Roger VL
Am Heart J; 2017 Mar; 185():74-84. PubMed ID: 28267478
[TBL] [Abstract][Full Text] [Related]
3. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.
Chen N; Alam AB; Lutsey PL; MacLehose RF; Claxton JS; Chen LY; Chamberlain AM; Alonso A
J Am Heart Assoc; 2020 Jun; 9(11):e015089. PubMed ID: 32448024
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.
Subramanya V; Claxton JS; Lutsey PL; MacLehose RF; Chen LY; Chamberlain AM; Norby FL; Alonso A
BMC Cardiovasc Disord; 2021 Dec; 21(1):598. PubMed ID: 34915858
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
Millenaar D; Schumacher H; Brueckmann M; Eikelboom JW; Ezekowitz M; Slawik J; Ewen S; Ukena C; Wallentin L; Connolly S; Yusuf S; Böhm M
Am J Cardiol; 2021 Jun; 149():27-35. PubMed ID: 33757788
[TBL] [Abstract][Full Text] [Related]
9. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
10. Integrated care and outcomes in patients with atrial fibrillation and comorbidities.
Proietti M; Vitolo M; Lip GYH
Eur J Clin Invest; 2021 Jun; 51(6):e13498. PubMed ID: 33482011
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry).
An Y; Ogawa H; Esato M; Ishii M; Iguchi M; Masunaga N; Fujino A; Ide Y; Hamatani Y; Doi K; Ikeda S; Ishigami K; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
Am J Cardiol; 2020 Nov; 134():74-82. PubMed ID: 32900468
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records.
Hulme OL; Khurshid S; Weng LC; Anderson CD; Wang EY; Ashburner JM; Ko D; McManus DD; Benjamin EJ; Ellinor PT; Trinquart L; Lubitz SA
JACC Clin Electrophysiol; 2019 Nov; 5(11):1331-1341. PubMed ID: 31753441
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction.
Chamberlain AM; Boyd CM; Manemann SM; Dunlay SM; Gerber Y; Killian JM; Weston SA; Roger VL
Am J Med; 2020 Jun; 133(6):e237-e248. PubMed ID: 31747542
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
Coleman CI; Kreutz R; Sood NA; Bunz TJ; Eriksson D; Meinecke AK; Baker WL
Am J Med; 2019 Sep; 132(9):1078-1083. PubMed ID: 31054829
[TBL] [Abstract][Full Text] [Related]
18. Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands.
van Doorn S; Tavenier A; Rutten FH; Hoes AW; Moons KGM; Geersing GJ
BMJ Open; 2018 Aug; 8(8):e021681. PubMed ID: 30139900
[TBL] [Abstract][Full Text] [Related]
19. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
[TBL] [Abstract][Full Text] [Related]
20. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
